Drug-Induced Progressive Multifocal Leukoencephalopathy: A Comprehensive Analysis of the WHO Adverse Drug Reaction Database
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Drug-Induced Progressive Multifocal Leukoencephalopathy: A Comprehensive Analysis of the WHO Adverse Drug Reaction Database
Authors
Keywords
Systemic Lupus Erythematosus, Progressive Multifocal Leukoencephalopathy, Natalizumab, Acquire Immune Deficiency Syndrome, Anatomical Therapeutic Chemical
Journal
CNS DRUGS
Volume 29, Issue 10, Pages 879-891
Publisher
Springer Nature
Online
2015-10-27
DOI
10.1007/s40263-015-0286-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PML in a Patient without Severe Lymphocytopenia Receiving Dimethyl Fumarate
- (2015) Dennis J. Nieuwkamp et al. NEW ENGLAND JOURNAL OF MEDICINE
- PML in a Patient with Lymphocytopenia Treated with Dimethyl Fumarate
- (2015) Thorsten Rosenkranz et al. NEW ENGLAND JOURNAL OF MEDICINE
- A case report of progressive multifocal leucoencephalopathy (PML) associated with adalimumab
- (2014) Manoj Ray et al. ANNALS OF THE RHEUMATIC DISEASES
- Monoclonal Antibodies and Progressive Multifocal Leukoencephalopathy
- (2014) Daniel L. Keene et al. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
- Progressive multifocal leukoencephalopathy: new concepts
- (2013) Marco A. Lima ARQUIVOS DE NEURO-PSIQUIATRIA
- New Insights on Human Polyomavirus JC and Pathogenesis of Progressive Multifocal Leukoencephalopathy
- (2013) Anna Bellizzi et al. Clinical & Developmental Immunology
- Progressive Multifocal Leukoencephalopathy Associated with Ruxolitinib
- (2013) Rowan Wathes et al. NEW ENGLAND JOURNAL OF MEDICINE
- PML in a Patient Treated with Fumaric Acid
- (2013) Ummehan Ermis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Disproportionality signal of progressive multifocal leukoencephalopathy: monoclonal antibodies versus other immunosuppressants
- (2013) Carlo Piccinni et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Molecular Biology, Epidemiology, and Pathogenesis of Progressive Multifocal Leukoencephalopathy, the JC Virus-Induced Demyelinating Disease of the Human Brain
- (2012) M. W. Ferenczy et al. CLINICAL MICROBIOLOGY REVIEWS
- Systemic Lupus Erythematosus, Progressive Multifocal Leukoencephalopathy, and T-CD4+ Lymphopenia
- (2012) Mariana Brandão et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Underreporting in pharmacovigilance: an intervention for Italian GPs (Emilia–Romagna region)
- (2012) Chiara Biagi et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Update on PML and PML-IRIS Occurring in Multiple Sclerosis Patients Treated With Natalizumab
- (2012) B.K. Kleinschmidt-DeMasters et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Signals of progressive multifocal leukoencephalopathy for immunosuppressants: a disproportionality analysis of spontaneous reports within the US Adverse Event Reporting System (AERS)
- (2012) Niklas Schmedt et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- History and current concepts in the pathogenesis of PML
- (2011) E. O. MAJOR CLEVELAND CLINIC JOURNAL OF MEDICINE
- Progressive multifocal leukoencephalopathy: an unexpected complication of modern therapeutic monoclonal antibody therapies
- (2011) E. Tavazzi et al. CLINICAL MICROBIOLOGY AND INFECTION
- A case of progressive multifocal leukoencephalopathy in a patient treated with infliximab
- (2010) Deepak Kumar et al. ARTHRITIS AND RHEUMATISM
- Progressive multifocal leukoencephalopathy: A national estimate of frequency in systemic lupus erythematosus and other rheumatic diseases
- (2009) Eamonn S. Molloy et al. ARTHRITIS AND RHEUMATISM
- Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project
- (2009) Kenneth R Carson et al. LANCET ONCOLOGY
- Quantitative signal detection using spontaneous ADR reporting
- (2009) A. Bate et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Influence of Regulatory Measures on the Rate of Spontaneous Adverse Drug Reaction Reporting in Italy
- (2008) Domenico Motola et al. DRUG SAFETY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now